NOVITA PHARMACEUTICALS
Novita Pharmaceuticals, Inc. develops and offer drugs for treatment of cancer. The company was incorporated in 2010 and is based in New York, New York.
NOVITA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
+91 9216295095
Total Funding:
8.46 M USD
Similar Organizations
Pharmasonics
Pharmasonics is a developer of therapeutic ultrasound catheter-based technology.
Current Employees Featured
More informations about "Novita Pharmaceuticals"
Novita Pharmaceuticals
Novita is dedicated to developing first-in-class drugs to prevent and treat cancer metastasis and to boost anti-cancer immune responses. Cancer metastasis is associated with over 90% of …See details»
About – Novita Pharmaceuticals
Novita Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing first-in-class drugs to prevent and treat cancer metastasis as well as to boost anti …See details»
Novita Pharmaceuticals - Crunchbase Company Profile …
Novita Pharmaceuticals, Inc. develops and offer drugs for treatment of cancer. The company was incorporated in 2010 and is based in New York, New York. A small molecule inhibitor targeting fascin to reduce tumor growth and …See details»
Novita Pharmaceuticals - LinkedIn
Novita Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing first-in-class drugs to prevent and treat cancer metastasis as well as to boost anti …See details»
Novita Pharmaceuticals Appoints Stewart Campbell as Chief …
Novita Pharmaceuticals, Inc. ("Novita"), a privately held, clinical-stage pharmaceutical company dedicated to developing novel cancer drugs through its proprietary fascin inhibitor technology, …See details»
Novita Pharmaceuticals LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Novita Pharmaceuticals LLC of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Novita Pharmaceuticals - Funding, Financials, Valuation & Investors
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.See details»
Novita (Drug Discovery) - PitchBook
Jan 4, 2011 · Operator of a biopharmaceutical company intended to develop drugs to prevent and treat cancer metastasis and boost anti-cancer immune responses.See details»
Novita Pharmaceuticals - Contacts, Employees, Board Members, …
Novita Pharmaceuticals has 3 current employee profiles, including Chief Financial Officer & Board Member Christy Shue. Novita Pharmaceuticals is a developer of therapeutic drugs for the …See details»
Novita Pharmaceuticals Appoints Stewart Campbell as Chief
Oct 1, 2024 · Novita Pharmaceuticals, Inc. ("Novita"), a privately held, clinical-stage pharmaceutical company dedicated to developing novel cancer drugs through its proprietary …See details»
Novita Pharmaceuticals - Products, Competitors, Financials, …
Novita Pharmaceuticals is developing new drug molecules to prevent cancer metastasis by targeting a new gene target, fascin. Use the CB Insights Platform to explore Novita …See details»
News – Novita Pharmaceuticals
Novita to Present First-in-Class Fascin Inhibitor NP-G2-044 Phase 2 Results in Patients with Advanced and Metastatic Solid Tumors at 2024 ASCO Annual Meeting. Read More. …See details»
Novita Pharmaceuticals - VentureRadar
Novita Pharmaceuticals, Inc. is a biopharmaceutical startup developing target-specific small molecule drugs to treat cancer metastasis. The company is currently focusing on patients with …See details»
Novita Pharmaceuticals Appoints Dr. Jose Jimeno as Its Chief
Jun 11, 2024 · Novita Pharmaceuticals, Inc. ("Novita" or the "Company"), a privately held clinical-stage pharmaceutical company dedicated to developing novel cancer drugs based on its …See details»
Novita Pharmaceuticals Appoints Alan Wills as Its Chief ... - PRWeb
Feb 13, 2023 · Novita Pharmaceuticals, Inc. ("Novita" or the "Company"), a privately held clinical-stage pharmaceutical company dedicated to developing novel cancer drugs based on its …See details»
Novita Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.See details»
Novita Pharmaceuticals, Inc. - Center For Technology Licensing
Novita Pharmaceuticals, Inc. is a biopharmaceutical startup developing target-specific small molecule drugs to treat cancer metastasis. The company is currently focusing on patients with …See details»
Novita Pharmaceuticals to Present its Fascin Inhibitor NP-G2
May 20, 2021 · Fascin inhibitor NP-G2-044 is a first-in-class drug expected to block cancer metastasis as monotherapy and synergize with anti-PD-1 immune checkpoint inhibitors in …See details»
Phase 1A clinical trial of the first-in-class fascin inhibitor NP-G2 ...
May 28, 2021 · First-in-human dose escalation of ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor, in advanced malignancies. Preliminary results from a phase 1/2 …See details»
Clinical Trials – Novita Pharmaceuticals
A Phase 1 clinical trial was conducted at 3 U.S. centers: City of Hope; Honor Health; and Memorial Sloan Kettering Cancer Center. The trial enrolled late-stage treatment-refractory …See details»